NB200-631 Laminin Receptor antibody
see related secondary antibodiessee all 47 Laminin Receptor products
0.5 ml / US$ 485 no delivery possible
Quick Overview
Mouse anti Laminin Receptor MLuC5
Synonyms
Anti-34/67 kDa laminin receptor antibody, Anti-37LRP antibody, Anti-40S ribosomal protein SA antibody, Anti-67LR antibody, Anti-Colon carcinoma laminin-binding protein antibody, Anti-LAMBR antibody, Anti-Laminin Receptor 1 antibody, Anti-LAMR 1 antibody, Anti-LAMR1 antibody, Anti-LRP antibody, Anti-Multidrug resistance-associated protein MGr1-Ag antibody, Anti-NEM/1CHD4 antibody, Anti-p40 antibody, Anti-Ribosomal Protein SA antibody, Anti-RPSA antibody,
Product Description
Mouse anti Laminin Receptor MLuC5, Presentation: Aff - Purified. Product is tested for Flow cytometry ( F ), Paraffin Sections ( P ), Immunofluorescence ( IF )
Properties
| Applications | Flow cytometry ( F ), Paraffin Sections ( P ), Immunofluorescence ( IF ) |
| Reactivity | Human ( Hu ) |
| Presentation | Aff - Purified |
| Host | Mouse |
| Isotype | IgM |
| Clone | MLuC5 |
| Catalog Number | NB200-631 |
| Quantity | 0.5 ml |
| Price | US$ 485 no delivery possible |
| Delivery | Not USA/Canada |
| Manufacturer | Novus Biologicals Inc. |
| Datasheet |  http://www.novusbio.com/d ... |
Datasheet Extract
| Mouse Monoclonal anti-Laminin Receptor (MLuC5) | |
| Concentration | 0.2 mg/ml |
| Background | Laminin, one of the major glycoproteins of basement membrane, displays multiple biological activities which are mediated through its interaction with specific cell membrane receptors. Overexpression of laminin receptor is reportedly an independent prognostic factor in breast cancer and correlates with the dissemination of the tumor cells in bone marrow. Laminin receptor appears to play an important role in tumor invasion and metastasis. |
| Immunogen | Small cell lung carcinoma N592 live cells. |
| Format | Purification: Immunogen affinity purified Purity: Immunogen affinity purified BufferSystem: 10mM PBS, pH7.4, 0.2%BSA, |
| Applications | FACS, IHC-P, IF |
| Specificity | Species: Cross-reacts with Human. Not yet tested in other species. |
| References | 1. Carbone A; Gloghini A; Colombatti A; Castronovo V; Menard S. Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistry. Human Pathology, 1995, 26(5):541-6. 2. Gasparini G; Barbareschi M; Boracchi P; Bevilacqua P; Verderio P; Dalla Palma P; Menard S. 67-kDa laminin-receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer. International Journal of Cancer, 1995, 60(5):604-10. 3. Pellegrini R; Mariotti A; Tagliabue E; Bressan R; Bunone G; Coradini D; Della Valle G; Formelli F; Cleris L; Radice P; et al. Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide. Cell Growth and Differentiation, 1995, 6(7):863-9. 4. Colnaghi MI. The simultaneous expression of cerbB-2 oncoprotein and laminin receptor on primary breast tumors has a predicting potential analogous to that of the lymph node status. Advances in Experimental Med and Biology, 1994, 353:149-54. 5. Menard S; Squicciarini P; Luini A; Sacchini V; Rovini D; Tagliabue E; Veronesi P; Salvadori B; Veronesi U; Colnaghi MI. Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features. British Journal of Cancer, 1994, 69(6):1126-9. 6. Pellegrini R; Martignone S; Menard S; Colnaghi MI. Laminin receptor expression and function in small-cell lung carcinoma. International Journal of Cancer. Supplement, 1994, 8:116-20. 7. Romanov V; Sobel ME; pinto da Silva P; Menard S; Castronovo V. Cell localization and redistribution of the 67 kD laminin receptor and alpha 6 beta 1 integrin subunits in response to laminin stimulation: an immunogold electron microscopy study. Cell Adhesion and Communication, 1994, 2(3):201-9. 8. Martignone S; Menard S; Bufalino R; Cascinelli N; Pellegrini R; Tagliabue E; Andreola S; Rilke F; Colnaghi MI. Prognostic significance of the 67- kilodalton laminin receptor expression in human breast carcinomas. Journal of the National Cancer Institute, 1993, 85(5):398-402. 9. Martignone S; Pellegrini R; Villa E; Tandon NN; Mastroianni A; Tagliabue E; Menard S; Colnaghi MI. Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression. Clinical and Experimental Metastasis, 1992, 10(6):379-86. |
10 Secondary Antibodies
| Catalog No. | Name / Host | Presentation | Reactivity | ||||
|---|---|---|---|---|---|---|---|
| R1349B | Mouse IgA + IgG + IgM (H&L) | ||||||
| Goat | Biotin | 2 mg / US$ 355 | |||||
| R1349F | Mouse IgA + IgG + IgM (H&L) | ||||||
| Goat | FITC | 2 mg / US$ 335 | |||||
| R1349T | Mouse IgA + IgG + IgM (H&L) | ||||||
| Goat | TRITC | 2 mg / US$ 335 | |||||
| R1349TR | Mouse IgA + IgG + IgM (H&L) | ||||||
| Goat | Texas Red | 2 mg / US$ 355 | |||||
| R1349HRP | Mouse IgA + IgG + IgM (H&L) | ||||||
| Goat | HRP | 2 mg / US$ 365 | |||||
| R1349AP | Mouse IgA + IgG + IgM (H&L) | ||||||
| Goat | AP | 1 mg / US$ 385 | |||||
| SP1018F | Mouse IgM mu chain | ||||||
| Goat | FITC | Ms | 1 mg / US$ 375 | ||||
| SP1018R | Mouse IgM mu chain | ||||||
| Goat | PE | Ms | 0.1 mg / US$ 485 | ||||
| SP1018HRP | Mouse IgM mu chain | ||||||
| Goat | HRP | Ms | 1 mg / US$ 385 | ||||
| SP1018AP | Mouse IgM mu chain | ||||||
| Goat | AP | Ms | 0.8 mg / US$ 425 | ||||
Click here to see all secondary antibodies for 'NB200-631 Laminin Receptor'.
